DJIA 18,162.99 121.45 0.67%
NASDAQ 5,106.59 73.84 1.47%
S&P 500 2,123.48 19.28 0.92%
market minute promo


company name or ticker

Tracking Seth Klarman's Baupost Group Holdings - Q4 2012 Update

13-F Alert: Baupost Group Adds AIG Shares and Microsoft Call Options

Legendary Investor Icahn Still Slugging Away With Enzon Pharma

Legendary Investor Icahn Still Slugging Away With Enzon Pharma

Tuesday’s Small Cap BioPharma Investment And Catalyst Trade List

Tuesday's Small Cap Biopharma Investment And Catalyst Trade List

Enzon Pharmaceuticals Considers Sale of Assets, Company

Review will analyze selling parts or entirety of company

This Biotech Is Officially for Sale

Enzon is looking into "strategic alternatives" to "maximize shareholder value." We know what that means.

Benzinga's M&A Chatter for Monday December 17, 2012

U.S. HOT STOCKS FUTURES: HOT STOCKS TO WATCH

See More Articles...